BGB-58067
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BGB-58067, covering 2026-03-19 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Phase 0/2 PD-Trigger Study of BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors [EARLY_Phase 1]